Sort
30,917 grants matching “tumor microenvironment”
BRAFV600E and VEGFR2 synergize to trigger papillary thyroid cancer progression
$361,050Carmelo Nucera · Beth Israel Deaconess Medical Center · R01 · FY2014 · CA
BRAFV600E and VEGFR2 synergize to trigger papillary thyroid cancer progression
$361,050Carmelo Nucera · Beth Israel Deaconess Medical Center · R01 · FY2018 · CA
Tumor Immunology & Host Response
$361,047Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2014 · CA
Control of quiescence and outgrowth in latent breast preneoplastic cells
$361,029Cheuk Tung Leung · University Of Minnesota · R01 · FY2018 · CA
Tumor Microenvironment in Modulating the Primary & Metastatic Brain Tumors
$361,019Johanna Joyce · Sloan-Kettering Inst Can Research · U54 · FY2008 · CA
Dissecting the Function of Cysteine Cathepsins in the Tumor Microenvironment
$361,000Johanna Joyce · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA
Dissecting the Function of Cysteine Cathepsins in the Tumor Microenvironment
$361,000Johanna Joyce · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA
In vivo monitoring of tumor microenvironment regulation for macrophages
$361,000Valery V Khramtsov · West Virginia University · R01 · FY2022 · CA
Osteoclast-Independent Mechanisms of Early-Stage Bone Colonization of Breast Cancer
$361,000Xiang Zhang · Baylor College Of Medicine · R01 · FY2024 · CA
Dissecting the Function of Cysteine Cathepsins in the Tumor Microenvironment
$361,000Johanna Joyce · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
Dissecting the Function of Cysteine Cathepsins in the Tumor Microenvironment
$361,000Johanna Joyce · Sloan-Kettering Inst Can Research · R01 · FY2008 · CA
In vivo monitoring of tumor microenvironment regulation for macrophages
$361,000Timothy D Eubank · West Virginia University · R01 · FY2025 · CA
RNAi screen of the glioblastoma stem cell kinome under hypoxia and normoxia
$360,938Brent H. Cochran · Tufts University Boston · R01 · FY2012 · NS
RNAi screen of the glioblastoma stem cell kinome under hypoxia and normoxia
$360,938Brent H. Cochran · Tufts University Boston · R01 · FY2015 · NS
RNAi screen of the glioblastoma stem cell kinome under hypoxia and normoxia
$360,938Brent H. Cochran · Tufts University Boston · R01 · FY2011 · NS
Mechanisms of lincDUSP Oncogenic Effects in Colon Cancer
$360,922Thomas Louis Laframboise · Case Western Reserve University · R01 · FY2022 · CA
Molecular mechanism and preclinical development of BETi and PARPi combination therapy
$360,922Lin Zhang · University Of Pennsylvania · R01 · FY2023 · CA
Mechanisms of lincDUSP Oncogenic Effects in Colon Cancer
$360,922Thomas Louis Laframboise · Case Western Reserve University · R01 · FY2023 · CA
Immunologic aspects of targeted therapy of erbB tumors
$360,922Mark I Greene · University Of Pennsylvania · R01 · FY2022 · CA
Molecular mechanism and preclinical development of BETi and PARPi combination therapy
$360,922Lin Zhang · University Of Pennsylvania · R01 · FY2022 · CA
Role of Perivascular Mesenchymal Stem Cells (pMSCs) in the Bone Marrow Niche and the Extracellular Matrix in the Control of Skeletal Metastasis
$360,922Rodrigo Alfonso Somoza · Case Western Reserve University · R01 · FY2023 · CA
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$360,922Malay Haldar · University Of Pennsylvania · R37 · FY2023 · CA
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer
$360,922Saori Furuta · Case Western Reserve University · R01 · FY2023 · CA
Identification and characterization of cancer cell states by novel computational and experimental technologies - Resubmission - 1
$360,869Itai Yanai · New York University School Of Medicine · U01 · FY2025 · CA
Tumor and Stromal Metalloproteinases in Breast Cancer
$360,864Lynn M Matrisian · Vanderbilt University · R01 · FY2011 · CA